Loading provider…
Loading provider…
Ophthalmology Physician in Los Angeles, CA
NPI: 1285714360Primary Employer
Neuroeyeorbit Institute
neuroeyeorbit.com
HQ Phone
Get MD Swaraj's Phone Numberphone_androidMobile
Get MD Swaraj's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
1998 - 2026

American Board of Ophthalmology
Ophthalmology
NYU Grossman School of Medicine
med.nyu.edu
Residency • Ophthalmology
1995 - 1998
Residency • Internal Medicine
1994 - 1995
Internship • Transitional Year
1993 - 1994
All India Institute of Medical Sciences
Medical School
Until 1981
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 92133Diagnostic imaging of optic nerve of eye | 716 | 1,042 |
| 2 | 92083Measurement of field of vision during daylight conditions | 671 | 911 |
| 3 | 99214Established patient office or other outpatient visit, 30-39 minutes | 501 | 797 |
| 4 | 92060Exam to measure eye deviation and range of motion | 344 | 550 |
| 5 | 99204New patient office or other outpatient visit, 45-59 minutes | 309 | 309 |
Epileptic monocular nystagmus.
Authors: Tobias Loddenkemper
Journal: Neurology
Effects of Hyperthyroidism on the Rectus Muscles in Mice
Authors: Nien, Chyong Jy, Jester, James V, Bose, Swaraj
Journal: Front Neurol
Publication Date: 2010-11-11
Effects of hyperthyroidism on the rectus muscles in mice.
Authors: Chyong Nien, James Jester, Swaraj Bose
Publication Date: 2010-09-12
Lead Sponsor: Jaeb Center for Health Research
Collaborators: National Eye Institute (NEI), University of Iowa, Icahn School of Medicine at Mount Sinai
Intervention / Treatment: DRUG: Acetazolamide, PROCEDURE: Optic Nerve Sheath Fenestration, PROCEDURE: Ventriculoperitoneal CSF Shunting
Lead Sponsor: Quark Pharmaceuticals
Intervention / Treatment: DRUG: QPI-1007 Injection - 3.0 mg, OTHER: Sham Injection Procedure, DRUG: QPI-1007 Injection - 1.5 mg